معرفی
Shannon Buckley is an Associate Professor of Hematology and Adjunct Associate Professor of Oncological Sciences at the University of Utah School of Medicine, where her research investigates molecular mechanisms in leukemia and lymphoma with emphasis on the ubiquitin proteasome system's role in hematopoietic cell fate decisions.
Her educational background includes:
- B.A. from University of St. Thomas - Minnesota
- Ph.D. from University of Minnesota
Dr. Buckley's research program centers on Leukemia, Lymphoma, Hematopoietic Stem Cells, Ubiquitination, and Proteomics, specifically studying posttranslational modifications by ubiquitin E3 ligases (FBOX family proteins and UBR5) in self-renewal, differentiation, and malignant transformation. Her lab employs genomic/proteomic approaches and mouse models to identify therapeutic targets in acute myeloid leukemia and mantle cell lymphoma through analysis of primary patient samples.
Analysis of her 2020-2024 publications reveals consistent focus on specific E3 ligases (FBXO21, FBXO9, UBR5) across hematopoietic malignancies, bridging basic protein degradation mechanisms with translational applications for cancer therapy, particularly highlighting the druggability of the ubiquitin proteasome system.
Scientific Awards:
- No scientific awards were mentioned in the provided text
There is no information available regarding student advising relationships or research grant funding in the source material.
Dr. Buckley directs a research laboratory focused on ubiquitin E3 ligase functions in hematopoietic cancers, utilizing multi-omics techniques to characterize molecular pathways in primary AML and MCL samples with the goal of developing targeted therapies against the ubiquitin proteasome system.
